The clinical evaluation of silent adrenal masses

Journal of Endocrinological Investigation

Volumn 20, Issue 2, 1997, Pages 90-107

  Ambrosi, B ^a,b   Passini, E ^a   Re, T ^a   Barbetta, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

ACTH; Adrenal adenoma; Adrenal tumor; Congenital adrenal hyperplasia; Cushing's syndrome; Hypercortisolism; Incidentaloma

Indexed keywords

ANDROSTENEDIONE; CATECHOLAMINE; COLLAGEN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; PRASTERONE SULFATE; SOMATOSTATIN RECEPTOR;

ADRENAL SCINTISCANNING; ADRENAL TUMOR; ADRENALECTOMY; BONE METABOLISM; CARBOHYDRATE METABOLISM; CATECHOLAMINE URINE LEVEL; COLLAGEN METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CUSHING SYNDROME; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ETHNIC GROUP; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MULTIPLE ENDOCRINE NEOPLASIA; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRACTICE GUIDELINE; REVIEW; SEX DIFFERENCE;

EID: 0030948174     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347983     Document Type: Review

References (111)

1. Lewinsky B.S., Grigor K.M., Symington T., Neville A.M. The clinical and pathologic feature of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer 33: 778, 1974.
2. Copeland P.M. The incidentally discovered adrenal mass. Ann. Intern. Med. 98: 940, 1983.
3. Ross N.S., Aron D.C. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N. Engl. J. Med. 323: 1401, 1990.
4. Gross M.D., Shapiro B. Clinically silent adrenal masses. J. Clin. Endocrinol. Metab. 77: 885, 1993.
5. Belldegrun A., Hussain S., Seltzer S.E., Loughlin K.R., Gittes R.F., Richie J.P. Incidentally discovered mass of the adrenal gland. Surg. Gynecol. Obstet. 163: 203, 1986.
6. Herrera M.F., Grant C.S., Van Heerden J.A., Sheedy P.F., Ilstrup D.M. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110: 1014, 1991.
7. Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses. Endocr. Rev. 16: 460, 1995.
8. Devenyi I. Possibility of normokalaemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas. J. Clin. Pathol. 20: 49, 1967.
9. Russell R.P., Masi A.T., Richter E.D. Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 51: 211, 1972.
10. Angeli A., Terzolo M., Osella G., Ali A. Adrenal incidentaloma (I): an overview of clinical and epidemiological data from the National Italian Study Group. 39èmes Journ. Intern. H.-P. Klotz Endocrin. Clin. Paris, 30-31 may 1996, (abs), p. 49, 1996.
11. Hedeland H., Ostberg G., Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med. Scand. 184: 211, 1968.
12. Kokko J.P., Brown T.C., Berman M.M. Adrenal adenoma and hypertension. Lancet 1: 468, 1967.
13. Dobbie J.W. Adrenocortical nodular hyperplasia: the aging adrenal. J. Pathol. 99: 1, 1969.
14. Granger P., Genest J. Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can. Med. Assoc. J. 103: 34, 1970.
15. Neville A.M. The nodular adrenal. Invest. Cell. Pathol. 1: 99, 1978.
16. Reznek H.R., Armstrong P. Imaging in endocrinology. The adrenal gland. Clin. Endocrinol. 40: 561, 1994.
17. Lee M.J., Hahn P.F., Papanicolau N., Egglin T.K., Saini S., Mueller P.R., Simeone J.F. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179: 415, 1991.
18. Reining J.W., Doppman J.L., Dwyer A.J., Johnson A.R., Knop R.H. Adrenal masses differentiated by MR. Radiology 158: 81, 1986.
19. Chezmar J.L., Robbins S.M., Nelson R.C., Steinberg H.V., Torres W.E., Bernardino M.E. Adrenal masses: characterization with T1 weighted MR imaging. Radiology 166: 357, 1988.
20. Mitchell D.G., Crovello M., Matteucci T.. Petersen R.O., Miettinen M.M. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185: 345, 1992.
21. Baker M.E., Blinder R., Spritzer C., Leight G.S., Herfkens R.J., Dunnick N.R. MR evaluation of adrenal masses at 1.5 T. Am. J. Roentgenol. 153: 307, 1989.
22. van Erkel A.R., van Gils A.P., Lequin M., Kruitwagen C., Bloem J.L., Falke T.H. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J. Comput. Assist. Tomogr. 18: 432, 1994.
23. Reining W.J., Stutley J.E., Leonhardt C.M., Spicer K.M., Magrolis M., Cadwell C.B. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 192: 41, 1994.
24. Gross M.D., Shapiro B., Francis I.R., Glazer G.M., Bree R.L., Arcomano M.A., Schtemgart D.E., Mc Leod M.K., Sanfield J.A., Thompson N.W. Scintigraphic evaluation of clinically silent adrenal masses (see comments). J.Nucl. Med. 35: 1145, 1994.
25. Khafagi F.A., Gross M.D., Shapiro B., Glazer G.M., Francis I., Thompson N.W. Clinical significance of the large adrenal mass. Br. J. Surg. 78: 828, 1991.
26. Gross M.D., Shapiro B., Francis I.R., Bree R.L., Korobkin M., McLeod M.K., Thompson N.W., Sanfield J.A. Scintigraphy of incidentally discovered bilateral adrenal masses. Eur. J. Nucl. Med. 22: 315, 1995.
27. Bardet S., Rohmer V., Murat A., Guillemot C., Marechaud R., Chupin M., Lecomte P., Simon D., Delemer B., Schneebelli S., Beutter D., Jacquin V., Peltier P., Charbonnel B. and the West France Study Group on Incidentalomas (WFSGI). 131-I-6β-lodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin. Endocrinol. (Oxf). 44: 587, 1996.
28. Lavoie H., Lacroix A. Partially autonomous cortisol secretion by incidentally discovered adrenal adenomas. Trends Endocrinol. Metab. 6: 191, 1995.
29. Chatal T., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating phaeochromocytoma. J. Clin. Endocrinol. Metab. 61: 769, 1985.
30. Gross M.D., Shapiro B.S. Scintigraphic studies in adrenal hypertension. Semin. Nucl. Med. 19: 122, 1989.
31. van Gils A.P., Falke T.H., van Erkel A.R., van de Velde C.J., Pauwels E.K. Non-invasive imaging of functioning paragangliomas (including phaeochromocytomas). Front. Eur. Radiol. 7: 1, 1990.
32. Mantero F., Masini A.M., Opocher G., Giovagnetti M., Amaldi G. Adrenal incidentaloma (2): an overview of hormonal data from the national Italian study group. 39èmes Journ. Intern. H.-P. Klotz Endocrin. Clin. Paris, 30-31 May 1996, (abs), p. 51, 1996.
33. Aso Y., Homma Y. A survey on incidental adrenal tumors in Japan. J. Urol. 147: 1478, 1992.
34. Hoefnagel C.A. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur. J. Nucl. Med. 21: 561, 1994.
35. Maurea S., Lastoria S., Caraco C., Klain M., Varrella P., Acampa W., Muto P., Salvatore M. The role of radiolabeled somatostatin analogs in adrenal imaging. Nucl. Med. Biol. 23: 677, 1996.
36. Gross M.D., Falke T.H.M., Shapiro B., Sandler M.P. Adrenal glands. In: Sandler M.P., Patton J.A., Gross M.D., Shapiro B., Falke T.H.M.(Eds.), Endocrine Imagines. Appleton and Lange, Norwalk, Connecticut, 1992, p. 271.
37. Bernardino M.E., Walther M.M., Phillips V.M., Graham Jr S.D., Sewell C.W., Gedgausas-McCless K., Baumgartner B.R., Torres W.E., Erwin B.C. CT-guided adrenal biopsy: accuracy, safety, and indications. Am. J. Roentgenol. 144: 67, 1985.
38. Yankaskas B.C., Staab E.V., Cravem M.B., et al. Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest. Radiol. 21: 325, 1986.
39. Oelkers W. Diagnostic puzzle of the adrenal "incidentaloma". Eur. J. Endocrinol. 132: 419, 1995.
40. Cook D.M., Loriaux D.L. The incidental adrenal mass. The Endocrinologist 6: 4, 1996.
41. Hensen J., Buhl M., Bähr V., Oelkers W. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing-hormone. Klin. Wochenschr. 68: 608, 1990.
42. Jockenhovel F., Kuck W., Hauffa B., Reinhardt W., Benker G., Lederbogen S., Olbricht Th., Reinwein D. Consecutive and surgical management of incidentally discovered adrenal tumors (incidentalomas). J. Endocrinol. Invest. 15: 331, 1992.
43. Flecchia D., Mazza E., Carlini M., Blatto A., Olivieri F., Serra G., Camanni F., Messina M. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin. Endocrinol. (Oxf). 42: 129, 1995.
44. Reincke M., Nieke J., Krestin G.P., Saeger W., Allolio B., Winkelmann W. Preclinical Cushing's syndrome in adrenal "Incidentalomas": comparison with adrenal Cushing's syndrome. J. Clin. Endocrinol. Metab. 75: 826, 1992.
45. Caplan R.H., Strutt P.J., Wickus G.G. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch. Surg. 129: 291, 1994.
46. Fernandezreal J.M., Ricartengel W., Simo R. Pre-clinical Cushing's syndrome: report of three cases and literature review. Horm. Res. 41: 5, 1994.
47. Ambrosi B., Peverelli S., Passini E., Re T., Ferrario R., Colombo P., Sartorio A., Faglia G. Abnormalities of endocrine function in patients with clinically "silent" adrenal mass. Eur. J. Endocrinol. 132: 422, 1995.
48. Bencsik Z., Izabolks I., Goth M., Voros A., Kaszas I., Gonczi J., Kovacs L., Dohan O., Szilagyi G. Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach. J. Intern. Med. 237: 585, 1995.
49. Terzolo M., Osella G., Alì A., Borretta G., Magro G., Termine A., Paccotti P., Angeli A. Different patterns of steroid secretion in patients with adrenal incidentaloma. J. Clin. Endocrinol. Metab. 81: 740, 1996.
50. Osella G., Terzolo M., Borretta G., Magro G., Alì A., Piovesan A., Paccotti P., Angeli A. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J. Clin. Endocrinol. Metab. 79: 1532, 1994.
51. Del Monte P., Bernasconi D., Bertolazzi L., Meozzi M., Badaracco B., Torre R., Marugo M. Increased 17-alfa-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause of effect? Clin. Endocrinol. (Oxf). 42: 273, 1995.
52. Bencsik Z., Szabolks I., Kovaks Z., Ferencz A., Voros A., Kaszas I., Bor K., Gonczi J., Goth M., Kovacs L., Dohan O., Szilagyi G. Low dehydroepiandrosterone sulfate (DHEAS-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumours. J. Clin. Endocrinol. Metab. 81: 126, 1996.
53. Toth M., Racz K., Varga I., Szucs N., Szabò P., Futò L., Kiss R., Glaz E. Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumours before and following adrenal surgery. The Endocrine Society, 10th Int. Congr. Endocrinol., San Francisco, USA, June 12-15, 1996, p. 3-618 (abs), 1996.
54. Seppel T., Schlaghecke R. Augmented 17 a-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumour ('incidentalomas'). Clin. Endocrinol. (Oxf). 41: 455, 1994.
55. Ravichandran R., Lafferty F., Mcginniss M.J., Taylor H.C. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81: 1776, 1996.
56. Jaresch S., Kornely E., Kley H.K., Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74: 685, 1992.
57. Bauman A., Bauman C.G. Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasia. JAMA 248: 3140, 1982.
58. Jaursch-Hancke C., Allolio B., Metzler U., Bidlingmaier F., Winkelmann W. Adrenocortical carcinoma in patients with untreated congenital adrenal hyperplasia (CAH). Acta Endocrinol. (Copenh.) (Oxf). 177 (Suppl.): 146, 1988.
59. Turton D.B., O'Brian J.T., Shakir M.M. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. J. Endocrinol. Invest. 15: 789, 1992.
60. Aupetit-Faisant B., Blanchouin-Emeric N., Tenenbaum F., Battaglia C., Tabarin A., Amar J., Kuttenn F., Warnet A., Assayag B., Chamontin B., Touraine P.H., Lebrun P., Maunand B., Benoit A., Bletry O., Noel S., Lorcy Y., Allanic H., Legrand J.C. Plasma levels of aldosterone versus aldosterone precursors: a way to estimate the malignancy of asymptomatic and nonsecretory adrenal tumors: a French retrospective multicentric study. J. Clin. Endocrinol. Metab. 80: 2715, 1995.
61. Suzuki H, Shibata H., MaruyamaT., Ishimura Y., Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids 60: 42, 1995.
62. Siren J.E., Haapiainem R.K., Huikuri K.T., Sivula A. Incidentalomas of the adrenal gland: 36 operated patients and review of literature. World J. Surg. 17: 634, 1993.
63. Seppel T., Becker A., Feldkamp J., Santen R., Schlaghecke R. Risk factors for adrenocortical malignancy in patients with incidentally discovered adrenal tumours. J. Endocrinol. 144 (Suppl.), P43 (abs.), 1995.
64. Hensen J., Walters P., Stark S., Buhl M., Vecsei P.,Shao X.J., Rico A.J., Dorr H.G., Oelkers W. Hypertension and plasma potassium in patients with "non-functioning" adrenocortical adenoma. The Endocrine Society, 77th Annual Meeting, Washington, June 1995, P3-45 (abs.), 1995.
65. Furlani L., Dellera A. Alberiche M., Guerriero A;, Muggeo M. Apparent 21-hydroxylase deficiency in incidentally discovered adrenal mass. J. Endocrinol. Invest. 19 (Suppl. 5): 178 (abs.), 1996.
66. Racz K., Pinet F., Marton T., Szende B., Glaz E., Corvol P. Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and "nonfunctioning" adrenal adenomas. J. Clin. Endocrinol. Metab. 77: 677, 1993.
67. Murakami C., Ishibashi M., Kondo M. Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Int. Med. 31: 803, 1992.
68. Bevan J.S., Rees A. Dexamethasone-suppressible adrenal tumour in untreated 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf). 44: 733, 1996.
69. Nagasaka S., Kubota K., Motegi T., Hayashi E., Ohta M., Takahashi T., Iwasaki Y., Koike M., Nishikawa T., Sasano H., Murakami T. A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma. Clin. Endocrinol. (Oxf). 44: 111, 1996.
70. Reincke M. Steroid secretions in patients with adrenal incidentalomas. J. Clin. Endocrinol. Metab. 81: 3811, 1996.
71. Passini E, Re T., Conti A., Sartorio A., Ambrosi B. Some aspects of preclinical Cushing's syndrome of adrenal origin. J. Endocrinol. Invest. 19 (Suppl. 5): 71 (abs.), 1996.
72. Tsagarakis S., Michaliou D., Vasilatou E., Nikolou H., Thalassinos N. Evidence for incomplete suppression of cortisol on low-dose dexamethasone suppression test in patients with adrenal incidentalomas. Eur. J. Endocrinol. (Suppl. 2): 130 (abs.), 1994.
73. Charbonnel B., Chatal J.F., Ozanne P. Does the corticoadrenal adenoma with "pre-Cushing's" syndrome exist? J. Nucl. Med. 22: 1059, 1981.
74. Beyer H.S., Doe R.P. Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J. Clin. Endocrinol. Metab. 62: 1317, 1986.
75. Bogner U., Eggens U., Hensen J., Oelkers W. Incidentally discovered ACTH-dependent adrenal adenoma presenting as "Pre-Cushing's syndrome". Acta Endocrinol. 111: 89, 1986.
76. Hensen J., Buhl M., Oelkers W. Diagnostisches und therapeutisches vorgehen bei patienten mit zufaellig entdeckten nebennierentumoren. In: Allolio B., Schulte H.M. (Eds.), Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer Verlag, Stuttgart, New York, 1990, p. 210.
77. McLeod M., Thompson N., Gross M., Bondenson A., Bondenson L. Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am. Surg. 56: 398, 1990.
78. Seppel T., Schlaghecke R. Subclinical hypercortisolism in incidentally detected adrenal adenoma. Deutch. Med. Wochen. 121: 503, 1996.
79. Kobayashi S., Seki T., Nonomura K., Gotoh T., Togashi M., Koyanagi T. Clinical experience of incidentally discovered adrenal tumor with particular reference to cortical function. J. Urol. 150: 8, 1993.
80. Hensen J., Buhl M., Oelkers W. The functional spectrum of adrenocortical adenomas. Med. Hypoth. 40: 217, 1993.
81. Bernini G., Sgrò M., Molea N., Franchi F. A documented clinical case of pre-Cushing's syndrome. The Endocrinologist 5: 377, 1995.
82. Tsuboi Y., Ishikawa S., Fujisawa G., Okada K., Saito T. Possible pre-Cushing's syndrome due to an adrenal adenoma incidentally discovered. Endocr. J. 42: 509, 1995.
83. Laudat M.H., Billaud L., Thomopoulos P., Vera O., Yllia A., Luton J.P. Evening urinary free corticoids: a screening test in Cushing's syndrome and incidentally discovered adrenal tumours. Acta Endocrinol. (Copenh) 119: 459, 1988.
84. Morio H., Terano T., Yamamoto K., Tomizuka T., Oeda T., Saito Y., Tamura Y., Sasano H. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor. Endocr. J. 43: 387, 1996.
85. Ambrosi B., Sartorio A. Preclinical Cushing's syndrome. Trends Endocrinol. Metab. 7: 113, 1996.
86. Loli P., Vignati F., Da Re N., Milella M., Gelli D. Incidentally discovered "nonhypersecretory adrenal adenomas": a scintigraphic and hormonal evaluation. The Endocrine Society, 77th Annual Meeting, Washington, June 1995, P3-44 (abs), 1995.
87. Morioka M., Ohashi Y., Komatsu F., Sawada K., Ebara S., Ohashi T., Kondo K. Preclinical Cushing's Syndrome: report of four cases and analysis of steroid contents in adenomas. Horm. Res. 46: 117, 1996.
88. Tobinaga J., Imai T., Funahashi H., Tanaka Y., Wada M., Morita T., Yamada F., Tsukamura K., Oiwa M., Kikumori T., Sasano H., Takagi H. Incidentally discovered adrenocortical adenomas are not fully nonfunctioning: immunohistochemical and dispersed adrenocortical cell study. Endocr. J. 43: 79, 1996.
89. Huiras C.M., Pehling G.B., Caplan R.H. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. JAMA 261:894, 1989.
90. Virkkala A., Valimaki M., Pelkonen R., Huikuri K., Kahri A., Kivisaari L., Korhonen T., Salmi J., Seppala P. Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinol. (Copenh.) 121: 67, 1989.
91. Rosen H.N., Swartz S.L. Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am. J. Med. 92: 213, 1992.
92. Sutton M.G., Sheps S.G., Lie J.T. Prevalence of clinically unsuspected phaeochromocytoma: a review of a 50-year autopsy series. Mayo Clin. Proc. 56: 354, 1981.
93. Krane N.K. Clinically unsuspected pheochromocytomas: experience at Henry Ford Hospital and a review of the literature. Ann. Intern. Med. 146: 54, 1986.
94. Yamakita N., Saitoh M., Mercado-Asis L.B. Asymptomatic adrenal tumor: 386 cases in Japan including seven of our own. Endocrinol. Jpn. 37: 671, 1990.
95. Mannelli M., Pupilli C., Lanzillotti R., Ianni L., Amorosi A., Credi G., Pratesi G. A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. J. Endocrinol. Invest. 16: 817, 1993.
96. Sone H.,Okuda Y., Nakamura Y., Ishikawa N., Yamaoka T., Kawakami Y., Odawara M., Matsushima T., Kaway K., Yamashita K. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma - a false-positive case of adrenocortical adenoma and literature review. Horm. Res. 46: 138, 1996.
97. Reincke M., Peter M., Karl M. Does 21-hydroxylase deficiency play a role in the pathogenesis of non-functional adrenal adenomas? Exp. Clin. Endocrinol. (Suppl.1) 102: 74, 1994.
98. Burgess J.R., Harle R.A., Tucker P., Parameswaran V., Davies P., Greenway T.M., Shepherd J.J. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch. Surg. 131: 699, 1996.
99. Terzolo M., Boccuzzi A., Alì A., Osella G., Luceri S., Matrella C., Arcuno L., Borriero M., Rovero E., Angeli A. 24-hour profile of blood pressure in patients with adrenal incidentaloma. Comparison with adrenal Cushing's Syndrome. The Endocrine Society, 10th Intern. Congr. Endocrinol., San Francisco, USA, June 12-15, 1996, P3-596 (abs), 1996.
100. Sartorio A., Conti A., Ferrario S., Passini E., Re T., Ambrosi B. Serum bone Gla protein (BGP) and carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in patients with Cushing's syndrome before and after surgery. Postgrad. Med. J. 72: 419, 1996.
101. Osella G., Terzolo M., Piovesan A., Alì A., Termine A., Reimondo G., Paccotti P., Angeli A. Markers of bone and collagen turnover in patients with adrenal incidentaloma. The Endocrine Society, 10th Intern. Congr. Endocrinol., San Francisco, USA, June 12-15, 1996, P3-623 (abs), 1996.
102. Sartorio A., Ambrosi B., Colombo P., Morabito F., Faglia G. Osteocalcin levels in Cushing's disease before and after treatment. Horm. Metab. Res. 20: 70, 1988.
103. Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone A., Osella G., Boccuzzi A., Paccotti P. Angeli A. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm. Metab. Res. 26: 234, 1994.
104. Mold J.W., Stein H.F. The cascade effect in the clinical care of patients. N. Engl. J. Med. 314: 512, 1986.
105. Abecassis M., Mc Loughlin M.J., Langer B., Kudlow J.E. Serendipitous adrenal masses: prevalence, significance and management. Am. J. Surg. 149: 783, 1985.
106. Glazer H.S., Weyman P.J., Sagel S.S., Levitt R.G., McClennan B.L. Nonfunctioning adrenal masses: incidental discovery on computed tomography. Am. J. Roentgenol. 139: 89, 1982.
107. Prinz R.A., Brooks M.H., Churchill R., Graner J.L., Lawrence A.M., Paloyan E., Sparagana M. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. JAMA 248: 701, 1982.
108. Thompson N.W., Cheung P.S.Y. Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasm including incidentalomas. Surg. Clin. North Am. 67: 423, 1987.
109. Gross M.D., Shapiro B., Bouffard J.A. et al. Distinguishing benign from malignant euadrenal masses. Ann. Intern. Med. 109: 613, 1988.
110. Weisnagel S.J., Gagner M., Breton G., Pomp A., Pharand D., Lacroix A. Laparoscopic adrenalectomy. The Endocrinologist 6: 169, 1996.
111. Griffing G.T. Editorial: A-I-D-S: the new endocrine epidemic. J. Clin. Endocrinol. Metab. 79: 1530, 1994.